HemaCare Co. (OTCMKTS:HEMA – Get Free Report)’s share price traded up 0.6% during mid-day trading on Thursday . The company traded as high as $25.31 and last traded at $25.31. 5,400 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Trading Up 0.6 %
The company’s 50-day moving average is $25.31 and its 200-day moving average is $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Further Reading
- Five stocks we like better than HemaCare
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- How to Use Stock Screeners to Find Stocks
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- Short Selling – The Pros and Cons
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
